Philadelphia Jury Slaps GSK With $2.5M Paxil Verdict
Law360 (October 13, 2009, 3:00 PM EDT) -- A Philadelphia jury on Tuesday returned a $2.5 million verdict against GlaxoSmithKline in a product liability case alleging that 3-year-old Lyam Kilker was born with a rare heart defect as a result of his mother's use of Paxil during pregnancy.
Within hours of the 10-2 verdict in the Philadelphia Court of Common Pleas, the drugmaker, part of U.K.-based pharmaceutical giant SmithKline Beecham Corp., said it would appeal.
"While we sympathize with Lyam Kilker and his family, the scientific evidence does not establish that exposure to Paxil during pregnancy caused his condition. Very unfortunately, birth defects occur in 3 to 5 percent...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!